Сравнение

Carbetocin vs. Glepaglutide

Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.

Идентичность

Категория

Исследования (прочее)

Номер CAS

37025-55-1

нет данных

Молекулярная масса

нет данных

Период полувыведения

0.67 h

нет данных

Последовательность

нет данных

Механизм действия

Carbetocin

Carbetocin is an oxytocin receptor agonist with prolonged duration. It triggers a sustained contraction of the uterus after birth, preventing atonic hemorrhage — unlike oxytocin, without a multi-hour infusion.

Glepaglutide

As a GLP-2 receptor agonist, glepaglutide has a trophic effect on the intestinal mucosa, enlarging the absorptive surface and thereby improving intestinal uptake of nutrients and fluid.

Доказательная база

Наивысшая доказательность

РКИ на людях

Исследования

из них на людях

Зафиксированные эффекты

Открытые противоречия

Задокументированные нежелательные явления

Правовой статус

Country	Carbetocin	Glepaglutide
Германия	Рецептурный	Не одобрено
США	Не одобрено	Не одобрено

Полные записи

Frequently asked questions

What is the difference between Carbetocin and Glepaglutide?: Carbetocin is classified as "Исследования (прочее)", while Glepaglutide is classified as "Исследования (прочее)". Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. Glepaglutide: Glepaglutide is a long-acting GLP-2 analogue (Zealand Pharma) intended to reduce the need for parenteral support in short bowel syndrome. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Carbetocin or Glepaglutide?: The highest available evidence level is "РКИ на людях" for Carbetocin and "РКИ на людях" for Glepaglutide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Carbetocin and Glepaglutide in Germany and the United States?: Германия: Carbetocin — Рецептурный, Glepaglutide — Не одобрено. США: Carbetocin — Не одобрено, Glepaglutide — Не одобрено. These are factual summaries with source and review date on the individual pages.

Country

Carbetocin

Glepaglutide

Германия

Рецептурный

Не одобрено

США

Не одобрено

Frequently asked questions

What is the difference between Carbetocin and Glepaglutide?

Carbetocin is classified as "Исследования (прочее)", while Glepaglutide is classified as "Исследования (прочее)". Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. Glepaglutide: Glepaglutide is a long-acting GLP-2 analogue (Zealand Pharma) intended to reduce the need for parenteral support in short bowel syndrome. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Carbetocin or Glepaglutide?

The highest available evidence level is "РКИ на людях" for Carbetocin and "РКИ на людях" for Glepaglutide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Carbetocin and Glepaglutide in Germany and the United States?

Германия: Carbetocin — Рецептурный, Glepaglutide — Не одобрено. США: Carbetocin — Не одобрено, Glepaglutide — Не одобрено. These are factual summaries with source and review date on the individual pages.